(Q87482651)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082626%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

title

First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082626%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082626%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Jan Lycke

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082626%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

author name string

Bengt A Andersson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082626%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

publication date

1 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082626%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082626%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

volume

261

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082626%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082626%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

page(s)

2016-2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082626%20AND%20SRC:MED&resulttype=core&format=json

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

11 March 2020

cites work

1 reference

12 December 2020

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

1 reference

12 December 2020

The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes

1 reference

12 December 2020

Prediction of type 1 diabetes in the general population

1 reference

12 December 2020

Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review

1 reference

12 December 2020

Etiology of type 1 diabetes

1 reference

12 December 2020

Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort

1 reference

12 December 2020

Pathogenesis of type 1 diabetes: lessons from natural history studies of high-risk individuals

1 reference

12 December 2020

Prediction and pathogenesis in type 1 diabetes.

1 reference

12 December 2020

10.1007/S00415-014-7448-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082626%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference